Past catalysts on this ticker, reconciled against the announcement parse pipeline. Hover any row for the parsed outcome detail.
AirSense 11's own upcoming catalysts alongside class-defining historical readouts and upcoming primary completion dates in the same mechanism classes. Each event moves the broader thesis for AirSense 11. Showing past 6 months and next 12 months · 5 later hidden.
Same axes, same units. Discontinued and historical pivotal trials excluded; see Competitor Landscape below for the full set.
| Trial | Sponsor | Class | Phase / Line | Design | Primary endpoint | Dosing | Key eligibility | n |
|---|---|---|---|---|---|---|---|---|
| AirSense 11 | ResMed | Drug Delivery Device | Approved | 0 | ||||
| CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea | Hospital Universitario Ramon y Cajal | — | Phase 4 |
Read-across commentary attached per trial. Phase ordering preserved within each group.
External analyst notes, journalism, and industry commentary cited with attribution.
"Sponsor guided" dates come from IR materials and earnings calls; hover for the cited source. "CT.gov proxy" dates fall back to the registry primary completion date — actual readouts typically follow by 3-6 months.
| — |
| — |
| — |
| — |
| — |
| CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea | Hospital Universitario La Paz | — | Phase 4 | — | — | — | — | — |
| Non-invasive Ventilation or CPAP in OSA-COPD Following Admission for an Acute Hypercapnic Respiratory Failure | Assistance Publique - Hôpitaux de Paris | — | Phase 3 | — | — | — | — | — |
| Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea | Yale University | — | Phase 3 | — | — | — | — | — |
| Do Endotypes Predict Response and Sequelae in OSA Patients | University of California, San Diego | — | Phase 2 | — | — | — | — | — |
| Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities | VA Office of Research and Development | — | PHASE1/PHASE2 | — | — | — | — | — |
| Impact of Exogenous Ketones on Sleep Apnea | Johns Hopkins University | — | PHASE1/PHASE2 | — | — | — | — | — |